title: Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B.
abstract: Botulinum neurotoxins (BoNTs) are among the most potent biological toxins for humans. Of the seven known serotypes (A-G) of BoNT, serotypes A, B and E cause most of the foodborne intoxications in humans. BoNTs in nature are associated with non-toxic accessory proteins known as neurotoxin-associated proteins (NAPs), forming large complexes that have been shown to play important roles in oral toxicity. Using mouse intraperitoneal and oral models of botulism, we determined the dose response to both BoNT/B holotoxin and complex toxins, and compared the toxicities of BoNT/B and BoNT/A complexes. Although serotype A and B complexes have similar NAP composition, BoNT/B formed larger-sized complexes, and was approximately 90 times more lethal in mouse oral intoxications than BoNT/A complexes. When normalized by mean lethal dose, mice orally treated with high doses of BoNT/B complex showed a delayed time-to-death when compared with mice treated with BoNT/A complex. Furthermore, we determined the effect of various food matrices on oral toxicity of BoNT/A and BoNT/B complexes. BoNT/B complexes showed lower oral bioavailability in liquid egg matrices when compared to BoNT/A complexes. In summary, our studies revealed several factors that can either enhance or reduce the toxicity and oral bioavailability of BoNTs. Dissecting the complexities of the different BoNT serotypes and their roles in foodborne botulism will lead to a better understanding of toxin biology and aid future food risk assessments.
authors: Foodborne Contaminants Research Unit, Western Regional Research Center, U.S. Department of Agriculture, Agricultural Research Service, 800 Buchanan Street, Albany, CA 94710, USA. Luisa.Cheng@ars.usda.gov
authors: Luisa W
authors: LW
authors: Cheng
authors: Thomas D
authors: TD
authors: Henderson
references: PLoS One. 2007 Dec 05;2(12):e1271
references: 18060065
references: Infect Immun. 1984 Feb;43(2):487-90
references: 6693168
references: Infect Immun. 1977 Jun;16(3):910-4
references: 19355
references: J Bacteriol. 2007 Feb;189(3):818-32
references: 17114256
references: Appl Environ Microbiol. 2005 Aug;71(8):4478-86
references: 16085839
references: JAMA. 2001 Feb 28;285(8):1059-70
references: 11209178
references: J Biol Chem. 2007 Aug 24;282(34):24777-83
references: 17581814
references: Biochim Biophys Acta. 2007 Apr;1770(4):551-5
references: 17196748
references: FEBS J. 2005 Jun;272(11):2717-26
references: 15943806
references: Infect Immun. 1996 May;64(5):1589-94
references: 8613365
references: Infect Immun. 1977 Apr;16(1):107-9
references: 326664
references: Toxicology. 2005 Oct 30;214(3):210-20
references: 16087285
references: J Pharmacol Exp Ther. 2004 Aug;310(2):633-41
references: 15140915
references: Toxicon. 2009 Oct;54(5):583-6
references: 19073205
references: Cell Microbiol. 2008 Feb;10(2):355-64
references: 17868282
references: Toxicon. 2009 Apr;53(5):503-11
references: 19673096
references: Toxicon. 2011 Mar 15;57(4):555-65
references: 21195107
references: Infect Immun. 1998 Jun;66(6):2420-5
references: 9596697
references: J Biol Chem. 1998 Aug 21;273(34):21950-7
references: 9705335
references: FEMS Immunol Med Microbiol. 2007 Apr;49(3):346-52
references: 17378898
references: Annu Rev Pharmacol Toxicol. 2004;44:167-93
references: 14744243
references: J Pharmacol Exp Ther. 2005 Dec;315(3):1028-35
references: 16144978
references: Toxicology. 2008 Jul 30;249(2-3):123-9
references: 18538461
references: Can J Microbiol. 1977 Sep;23(9):1257-60
references: 332296
references: BMC Biol. 2009 Oct 05;7:66
references: 19804621
references: J Biomed Biotechnol. 2010;2010:974943
references: 20169001
references: Microbiology (Reading). 2009 Jan;155(Pt 1):35-45
references: 19118344